Description
Micoside-250 mg contains Terbinafine HCI, a potent antifungal agent that demonstrates strong fungicidal action against dermatophyte infections. It is highly effective in treating fungal infections caused by Trichophyton, Microsporum, Epidermophyton, and other pathogenic yeast species. The medication offers lower minimum inhibitory concentrations (MICs) compared to triazoles, imidazoles, and griseofulvin, ensuring superior treatment outcomes.
Micoside-250 mg has proven to be more effective than both itraconazole and fluconazole, particularly in the treatment of tinea capitis, and delivers higher clinical and mycological cure rates for fungal infections of the skin and nails.
Indications:
- Tinea corporis (ringworm of the body)
- Tinea cruris (jock itch)
- Tinea pedis (athlete’s foot)
- Onychomycosis (nail fungus)
Key Benefits:
- Effective fungicidal action with higher cure rates compared to fluconazole and griseofulvin.
- Treats dermatophyte infections with superior clinical outcomes.
- Proven efficacy in both skin and nail fungal infections.
Micoside-250 mg is a reliable antifungal treatment for dermatophyte infections, offering faster recovery and sustained relief from various fungal conditions affecting the skin and nails.